• Search

Rising to the Challenges of Human iPSC-derived Cells for Tox & Drug Screening

Rising to the challenges of human iPSC-derived cells in toc and drug discovery screening

We presented 'in the field' data on our portfolio of human iPSC and primary cells demonstrating their proven ease of use, reliability and consistency as meaningful drug discovery tools. Here, we overcome the challenges of cell line variability and address the needs for cell scale-up in assay campaigns.

Please fill in the form below to download the slides.